Quantitative measurement of cervical range of motion in patients with torticollis treated with botulinum A toxin
- 1 January 1993
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 8 (1) , 38-42
- https://doi.org/10.1002/mds.870080107
Abstract
Improvement in cervical range of motion in patients with spasmodic torticollis by botulinum A toxin injection is difficult to objectively measure. Recently, a three-dimensional cervical range of motion system (EMROM) that measures primary as well as secondary cervical angles has been developed. This system uses an electromagnetic tracking system for data collection and a personal computer for analysis and graphic display of the data. We have tested the EMROM system and, from our results, believe that it can be used clinically to objectively and accurately measure cervical range of motion in patients who have spasmodic torticollis and who receive botulinum toxin injections.Keywords
This publication has 7 references indexed in Scilit:
- An Electromagnetic Cervical Range-of-Motion System and Its Sensitivity to Environmental MetalAssistive Technology, 1990
- Botulinum toxin injections for cervical dystoniaNeurology, 1990
- Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollisNeurology, 1989
- Botulinum toxin in spasmodic torticollis.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Botulinum A toxin for cranial‐cervical dystoniaNeurology, 1987
- Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasmMovement Disorders, 1987
- DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLISThe Lancet, 1986